• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素D3的代谢途径:在细胞色素P450scc(CYP11A1)催化过程中形成的独特羟基化代谢产物。

A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1).

作者信息

Guryev O, Carvalho R A, Usanov S, Gilep A, Estabrook R W

机构信息

Department of Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9038, USA.

出版信息

Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14754-9. doi: 10.1073/pnas.2336107100. Epub 2003 Dec 1.

DOI:10.1073/pnas.2336107100
PMID:14657394
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC299797/
Abstract

Metabolites of vitamin D3 (D3) (cholecalciferol) are recognized as enzymatically formed chemicals in humans that can influence a wide variety of reactions that regulate a large number of cellular functions. The metabolism of D3 has been extensively studied, and a role for three different mitochondrial cytochrome P450s (CYP24A, CYP27A, and CYP27B1) has been described that catalyze the formation of the 24(OH), 25(OH), and 1(OH) metabolites of D3, respectively. The hormone 1,25-dihydroxyvitamin D3 has been most extensively studied and is widely recognized as a regulator of calcium and phosphorous metabolism. Hydroxylated metabolites of D3 interact with the nuclear receptor and thereby influence growth, cellular differentiation, and proliferation. In this article, we describe in vitro experiments using purified mitochondrial cytochrome P450scc (CYP11A1) reconstituted with the iron-sulfer protein, adrenodoxin, and the flavoprotein, adrenodoxin reductase, and show the NADPH and time-dependent formation of two major metabolites of D3 (i.e., 20-hydroxyvitamin D3 and 20,22-dihydroxyvitamin D3) plus two unknown minor metabolites. In addition, we describe the metabolism of 7-dehydrocholesterol by CYP11A1 to a single product identified as 7-dehydropregnenolone. Although the physiological importance of these hydroxylated metabolites of D3 and their in vivo formation and mode of action remain to be determined, the rate with which they are formed by CYP11A1 in vitro suggests an important role.

摘要

维生素D3(D3)(胆钙化醇)的代谢产物被认为是人体内通过酶促形成的化学物质,可影响多种调节大量细胞功能的反应。D3的代谢已得到广泛研究,已描述了三种不同的线粒体细胞色素P450(CYP24A、CYP27A和CYP27B1)的作用,它们分别催化D3的24(OH)、25(OH)和1(OH)代谢产物的形成。激素1,25-二羟基维生素D3的研究最为广泛,被广泛认为是钙和磷代谢的调节剂。D3的羟基化代谢产物与核受体相互作用,从而影响生长、细胞分化和增殖。在本文中,我们描述了使用纯化的线粒体细胞色素P450scc(CYP11A1)与铁硫蛋白、肾上腺皮质铁氧还蛋白和黄素蛋白、肾上腺皮质铁氧还蛋白还原酶重构进行的体外实验,并展示了NADPH和时间依赖性地形成D3的两种主要代谢产物(即20-羟基维生素D3和20,22-二羟基维生素D3)以及两种未知的次要代谢产物。此外,我们描述了CYP11A1将7-脱氢胆固醇代谢为一种单一产物,鉴定为7-脱氢孕烯醇酮。尽管D3的这些羟基化代谢产物的生理重要性及其体内形成和作用方式仍有待确定,但它们在体外由CYP11A1形成的速率表明其具有重要作用。

相似文献

1
A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1).维生素D3的代谢途径:在细胞色素P450scc(CYP11A1)催化过程中形成的独特羟基化代谢产物。
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14754-9. doi: 10.1073/pnas.2336107100. Epub 2003 Dec 1.
2
Production of 22-hydroxy metabolites of vitamin d3 by cytochrome p450scc (CYP11A1) and analysis of their biological activities on skin cells.维生素 D3 的 22- 羟基代谢物由细胞色素 P450scc(CYP11A1)产生,并分析其对皮肤细胞的生物活性。
Drug Metab Dispos. 2011 Sep;39(9):1577-88. doi: 10.1124/dmd.111.040071. Epub 2011 Jun 15.
3
A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin.一种在哺乳动物皮肤中7-脱氢胆固醇顺序转化及P450scc系统表达的新途径。
Eur J Biochem. 2004 Nov;271(21):4178-88. doi: 10.1111/j.1432-1033.2004.04356.x.
4
Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity.维生素 D3 或 7-脱氢胆固醇代谢产物经细胞色素 P450scc 作用后具有抗白血病效应,且低钙或无钙活性。
PLoS One. 2010 Mar 26;5(3):e9907. doi: 10.1371/journal.pone.0009907.
5
The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism.细胞色素P450scc系统开启了维生素D3代谢的一条替代途径。
FEBS J. 2005 Aug;272(16):4080-90. doi: 10.1111/j.1742-4658.2005.04819.x.
6
Metabolism of 25-hydroxyvitamin D3 by microsomal and mitochondrial vitamin D3 25-hydroxylases (CYP2D25 and CYP27A1): a novel reaction by CYP27A1.微粒体和线粒体维生素D3 25-羟化酶(CYP2D25和CYP27A1)对25-羟基维生素D3的代谢:CYP27A1的一种新反应。
Biochim Biophys Acta. 2003 Jun 10;1632(1-3):40-7. doi: 10.1016/s1388-1981(03)00062-3.
7
Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24.人CYP24催化的25-羟基维生素D3双代谢途径。
Eur J Biochem. 2000 Oct;267(20):6158-65. doi: 10.1046/j.1432-1327.2000.01680.x.
8
Hydroxylation of CYP11A1-derived products of vitamin D3 metabolism by human and mouse CYP27B1.人源和鼠源 CYP27B1 对 CYP11A1 来源的维生素 D3 代谢产物的羟化作用。
Drug Metab Dispos. 2013 May;41(5):1112-24. doi: 10.1124/dmd.113.050955. Epub 2013 Mar 1.
9
Characterization of cytochrome P450 CYP109E1 from Bacillus megaterium as a novel vitamin D hydroxylase.巨大芽孢杆菌细胞色素P450 CYP109E1作为一种新型维生素D羟化酶的特性研究。
J Biotechnol. 2017 Feb 10;243:38-47. doi: 10.1016/j.jbiotec.2016.12.023. Epub 2016 Dec 30.
10
C-25 hydroxylation of 1alpha,24(R)-dihydroxyvitamin D3 is catalyzed by 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1): metabolism studies with human keratinocytes and rat recombinant CYP24A1.1α,24(R)-二羟基维生素D3的C-25羟基化由25-羟基维生素D3-24-羟化酶(CYP24A1)催化:人角质形成细胞和大鼠重组CYP24A1的代谢研究
Arch Biochem Biophys. 2004 Nov 15;431(2):261-70. doi: 10.1016/j.abb.2004.08.023.

引用本文的文献

1
NMR-guided identification of CYP11A1-Adrenodoxin interactions that differentially govern cholesterol and vitamin D3 metabolism.核磁共振引导下对细胞色素P450 11A1-肾上腺皮质铁氧化还原蛋白相互作用的鉴定,这些相互作用以不同方式调控胆固醇和维生素D3代谢。
J Biol Chem. 2025 Jun 26;301(8):110428. doi: 10.1016/j.jbc.2025.110428.
2
Vitamin D and Immune Checkpoint Inhibitors in Lung Cancer: A Synergistic Approach to Enhancing Treatment Efficacy.维生素D与肺癌中的免疫检查点抑制剂:提高治疗效果的协同方法
Int J Mol Sci. 2025 May 9;26(10):4511. doi: 10.3390/ijms26104511.
3
Cholesterol-modifying strategies for Alzheimer disease: promise or fallacy?用于阿尔茨海默病的胆固醇调节策略:前景还是谬误?
Expert Rev Neurother. 2025 May;25(5):521-535. doi: 10.1080/14737175.2025.2483928. Epub 2025 Apr 3.
4
Anticancer Activity of Vitamin D, Lumisterol and Selected Derivatives against Human Malignant Melanoma Cell Lines.维生素 D、路美替醇及其选定衍生物对人恶性黑色素瘤细胞系的抗癌活性。
Int J Mol Sci. 2024 Oct 10;25(20):10914. doi: 10.3390/ijms252010914.
5
Biological Effects of CYP11A1-Derived Vitamin D and Lumisterol Metabolites in the Skin.CYP11A1 衍生的维生素 D 和路甾醇代谢物在皮肤中的生物学效应。
J Invest Dermatol. 2024 Oct;144(10):2145-2161. doi: 10.1016/j.jid.2024.04.022. Epub 2024 Jul 12.
6
Malignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling.恶性黑色素瘤:概述、新观点及维生素D信号传导
Cancers (Basel). 2024 Jun 18;16(12):2262. doi: 10.3390/cancers16122262.
7
Evolutionary formation of melatonin and vitamin D in early life forms: insects take centre stage.褪黑素和维生素 D 在早期生命形式中的进化形成:昆虫占据中心舞台。
Biol Rev Camb Philos Soc. 2024 Oct;99(5):1772-1790. doi: 10.1111/brv.13091. Epub 2024 Apr 30.
8
Light-driven progesterone production by InP-(M. neoaurum) biohybrid system.通过InP-(新金色链霉菌)生物杂交系统实现光驱动孕酮生产。
Bioresour Bioprocess. 2022 Sep 1;9(1):93. doi: 10.1186/s40643-022-00575-7.
9
Clinical and genetic determinants of vitamin D receptor expression in cutaneous melanoma patients.皮肤黑素瘤患者维生素 D 受体表达的临床和遗传决定因素。
Melanoma Res. 2024 Apr 1;34(2):125-133. doi: 10.1097/CMR.0000000000000929. Epub 2024 Feb 13.
10
Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts.新型维生素 D3 代谢物的抗纤维化活性需要维生素 D 受体或维甲酸相关孤儿受体的参与。
Cells. 2024 Jan 26;13(3):239. doi: 10.3390/cells13030239.

本文引用的文献

1
THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.肝微粒体的一氧化碳结合色素。I. 其血红蛋白性质的证据。
J Biol Chem. 1964 Jul;239:2370-8.
2
20alpha,22x-Dihydroxycholesterol, an intermediate in the biosynthesis of pregnenolone (3beta-hydroxypregn-5-en-20-one) from cholesterol.20α,22α-二羟基胆固醇,是胆固醇生物合成孕烯醇酮(3β-羟基孕-5-烯-20-酮)过程中的一种中间体。
J Biol Chem. 1962 Mar;237:699-702.
3
Conversion of 20-alpha-hydroxycholesterol to pregnenolone.20-α-羟基胆固醇向孕烯醇酮的转化。
Biochem Biophys Res Commun. 1961 Apr 28;4:460-3. doi: 10.1016/0006-291x(61)90308-4.
4
The isolation and properties of microsomal cytochrome.微粒体细胞色素的分离及特性
J Biol Chem. 1956 Jul;221(1):253-64.
5
De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase.细胞色素P450 2R1的去孤儿化:一种微粒体维生素D 25-羟化酶。
J Biol Chem. 2003 Sep 26;278(39):38084-93. doi: 10.1074/jbc.M307028200. Epub 2003 Jul 16.
6
Clinical importance of the cytochromes P450.细胞色素P450的临床重要性。
Lancet. 2002 Oct 12;360(9340):1155-62. doi: 10.1016/S0140-6736(02)11203-7.
7
Nuclear receptors and lipid physiology: opening the X-files.核受体与脂质生理学:解开神秘谜团
Science. 2001 Nov 30;294(5548):1866-70. doi: 10.1126/science.294.5548.1866.
8
The importance of residues in substrate recognition site 3 for the catalytic function of CYP2D25 (vitamin D 25-hydroxylase).底物识别位点3中的残基对CYP2D25(维生素D 25-羟化酶)催化功能的重要性。
Biochem Biophys Res Commun. 2001 Nov 9;288(4):1059-63. doi: 10.1006/bbrc.2001.5879.
9
Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein.维生素D内分泌系统的配体:不同形状的配体可作为基因组和快速反应受体的激动剂和拮抗剂,或作为血浆维生素D结合蛋白的配体。
J Steroid Biochem Mol Biol. 2001 Jan-Mar;76(1-5):49-59. doi: 10.1016/s0960-0760(00)00145-x.
10
Modern view of vitamin D3 and its medicinal uses.维生素D3的现代观点及其医学用途。
Prog Med Chem. 1998;35:1-56. doi: 10.1016/s0079-6468(08)70033-x.